Q2 2021 GT Biopharma Inc Earnings Call Transcript
Greetings, and welcome to the GT Biopharma second-quarter 2021 conference call. (Operator Instructions) At this time, I'd like to turn the conference call over to David Castaneda, Investor Relations for the company. Thank you. You may proceed.
Thank you, operator. Good morning, everyone, and welcome to GT Biopharma second-quarter 2021 conference call. Earlier this morning, we issued a press release summarizing the company's second-quarter 2021 corporate updates that management will discuss on the call today. You can access the press release by going to the News & Media section and then the press releases page on our website at gtbiopharma.com.
GT Biopharma's following presentation and ensuing question-and-answer session will include statements that are or may be deemed forward-looking statements. In some cases, you can identify forward-looking statements by terminology, including, anticipates, believes, can, continue, could, estimates, expects, intends, may, plans, potential, predicts, should, will, would or
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)